Efficacy of Triple-daily 15mA tACS on Adolescent NSSI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Triple-daily 15mA tACS on Adolescent NSSI — Stella

Home/Self-Injurious Behavior/

View on ClinicalTrials.gov

Recruiting

Back to Self-Injurious Behavior trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanghai Mental Health Center, Shanghai, Shanghai Municipality

Key details

Sponsor

Shanghai Mental Health Center

Enrollment target

~66 participants

Started

May 2025

Primary completion

September 2027

Age range

12 Years – 21 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.